S C Lazarus
Overview
Explore the profile of S C Lazarus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Leone F, Mauger E, Peters S, Chinchilli V, FISH J, Boushey H, et al.
Chest
. 2001 Apr;
119(4):1027-33.
PMID: 11296165
Study Objectives: Several methods of utilizing peak expiratory flow (PEF) and other markers of disease activity have been suggested as useful in the management of asthma. It remains unclear, however,...
12.
Israel E, Drazen J, Liggett S, Boushey H, CHERNIACK R, Chinchilli V, et al.
Am J Respir Crit Care Med
. 2000 Jul;
162(1):75-80.
PMID: 10903223
Inhaled beta-adrenergic agonists are the most commonly used medications for the treatment of asthma although there is evidence that regular use may produce adverse effects in some patients. Polymorphisms of...
13.
Lazarus S
Clin Rev Allergy Immunol
. 1999 Aug;
17(1-2):223-33.
PMID: 10436868
No abstract available.
14.
Liu H, Lazarus S, Caughey G, Fahy J
Am J Physiol
. 1999 Jan;
276(1):L28-34.
PMID: 9887052
Neutrophils, eosinophils, and their proinflammatory constituents are important mediators of airway disease, and high levels of neutrophil proteases and eosinophil cationic protein (ECP) are found in sputum from patients with...
15.
Lazarus S
J Clin Pharmacol
. 1998 Aug;
38(7):577-82.
PMID: 9702841
Asthma is an inflammatory disease that involves mast cells, antigen-presenting cells, eosinophils, neutrophils, and TH2-lymphocytes. These cells produce a broad array of mediators and cytokines that lead to the bronchoconstriction,...
16.
Lazarus S, Lee T, Kemp J, Wenzel S, Dube L, Ochs R, et al.
Am J Manag Care
. 1998 May;
4(6):841-8.
PMID: 10181070
Zileuton, a leukotriene pathway inhibitor used to treat asthma, improves lung function, relieves symptoms, and is well tolerated. The purpose of this 12-month, parallel-group, open-label study was to assess the...
17.
Lazarus S, Wong H, Watts M, Boushey H, Lavins B, Minkwitz M
Am J Respir Crit Care Med
. 1997 Dec;
156(6):1725-30.
PMID: 9412547
Inhalation of sulfur dioxide (SO2) causes bronchoconstriction in most people with asthma. To examine the role of leukotrienes in this response, the antagonism of SO2-induced bronchoconstriction by a single oral...
18.
FISH J, Peters S, Chambers C, McGeady S, Epstein K, Boushey H, et al.
Am J Respir Crit Care Med
. 1997 Nov;
156(4 Pt 1):1165-71.
PMID: 9351617
Colchicine demonstrates an array of anti-inflammatory properties of potential relevance to asthma. However, the efficacy of colchicine as an alternative to inhaled corticosteroid therapy for asthma is unknown. Five centers...
19.
Drazen J, Israel E, Boushey H, Chinchilli V, Fahy J, FISH J, et al.
N Engl J Med
. 1996 Sep;
335(12):841-7.
PMID: 8778601
Background: Inhaled beta-agonists are the most commonly used treatment for asthma, but data suggest that regularly scheduled use of these agents may have deleterious effect on the control of asthma....
20.
Thomas P, Pennington D, Schreck R, Levine T, Lazarus S
Clin Exp Allergy
. 1996 Jun;
26(6):710-8.
PMID: 8809429
Background: Previous studies have suggested varying molecular weights for mast cell derived tumour necrosis factor alpha (TNF alpha ) and little data exist upon the factors which may regulate the...